463 related articles for article (PubMed ID: 35760059)
1. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
2. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Cervical and Anal High-Risk Human Papillomavirus Infection in Women Living With HIV: An Observational Case-Control Study.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Das PK; Singh S; Gupta S
J Acquir Immune Defic Syndr; 2022 Nov; 91(3):319-324. PubMed ID: 35916635
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for anogenital HPV infection and neoplasia among women living with HIV in China.
Duan R; Zhang H; Wu A; Li C; Li L; Xu X; Qiao Y; Zhao F; Clifford G
Sex Transm Infect; 2022 Jun; 98(4):247-254. PubMed ID: 34187906
[TBL] [Abstract][Full Text] [Related]
6. Anal cytological abnormalities and human papillomavirus infection in women living with HIV: A systematic review and meta-analysis.
Gupta R; Kaur A; Sandeep ; Singh S; Gupta S
HIV Med; 2022 Apr; 23(4):378-389. PubMed ID: 35150185
[TBL] [Abstract][Full Text] [Related]
7. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
8. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
9. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
[TBL] [Abstract][Full Text] [Related]
11. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
[TBL] [Abstract][Full Text] [Related]
12. Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China.
Feng RM; Z Wang M; Smith JS; Dong L; Chen F; Pan QJ; Zhang X; Qiao YL; Zhao FH
J Clin Virol; 2018; 99-100():84-90. PubMed ID: 29396352
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of high-risk human papillomavirus infections and associated factors among women living with HIV in Shashemene town public health facilities, Southern Ethiopia.
Megersa T; Dango S; Kumsa K; Lemma K; Lencha B
BMC Womens Health; 2023 Mar; 23(1):125. PubMed ID: 36959649
[TBL] [Abstract][Full Text] [Related]
15. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
[TBL] [Abstract][Full Text] [Related]
16. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
[TBL] [Abstract][Full Text] [Related]
17. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
Wagner A; Skof AS; Sehouli J; Richter R; Henrich W; von Weizsäcker K; Siedentopf JP; Chekerov R; Kaufmann AM; Rohr I
Int J Gynecol Cancer; 2022 Jun; 32(6):716-723. PubMed ID: 35354606
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV-1 in Lao People's Democratic Republic.
Paboriboune P; Phongsavan K; Arounlangsy P; Flaissier B; Aphayarath O; Phimmasone P; Banchongphanith K; Xayaovong M; Jourdain G; Schott AM; Saadatian-Elahi M; Magaud L; Klich A; Ngo-Giang-Huong N; Heard I; Rabilloud M; Picot VS; Longuet C
Cancer Med; 2022 May; 11(9):1984-1994. PubMed ID: 35257506
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
